| . | Training set (n = 129 788) . | Validation set (n = 25 893) . | Testing set (n = 102 926) . |
|---|---|---|---|
| Age, years (SD) | 62.99 (16.3) | 63.09 (16.3) | 62.97 (16.3) |
| Age groups (%) | |||
| <40 | 12 674 (9.8) | 2508 (9.7) | 10 094 (9.8) |
| 40–49 | 12 978 (10.0) | 2542 (9.8) | 10 234 (9.9) |
| 50–59 | 22 301 (17.2) | 4466 (17.2) | 17 909 (17.3) |
| 60–69 | 31 231 (24.1) | 6202 (24.0) | 24 970 (24.2) |
| 70–79 | 30 984 (23.9) | 6242 (24.1) | 24 077 (23.3) |
| 80+ | 19 620 (15.1) | 3929 (15.2) | 15 642 (15.2) |
| Female sex (%) | 61 514 (47.3) | 12 288 (47.4) | 48 988 (47.5) |
| Male sex (%) | 68 274 (53.7) | 13 605 (53.6) | 53 938 (53.5) |
| AS measurement severity level (%) | |||
| No AS | 114 646 (88.3) | 90 763 (88.1) | |
| Mild AS | 10 194 (7.9) | 1991 (7.7) | 8330 (8.1) |
| Moderate AS | 1605 (1.2) | 300 (1.5) | 1225 (1.2) |
| Severe AS | 3343 (2.6) | 642 (2.5) | 2608 (2.5) |
| Congestive heart failure (%) | 23 399 (18.0) | 4733 (18.3) | 18 531 (18.0) |
| Peripheral vascular disease (%) | 20 102 (15.5) | 4178 (16.1) | 16 134 (15.7) |
| Cerebrovascular disease (%) | 14 787 (11.4) | 3002 (11.6) | 11 879 (11.5) |
| Renal disease (%) | 15 641 (12.1) | 3168 (12.2) | 12 394 (12.0) |
| Chronic pulmonary disease (%) | 26 312 (20.3) | 5210 (20.1) | 20 932 (20.3) |
| Connective tissue disease-rheumatic disease (%) | 6273 (4.8) | 1226 (4.7) | 5103 (5.0) |
| Myocardial infarction (%) | 12 097 (9.3) | 2446 (9.4) | 9843 (9.6) |
| Diabetes (%) | 22 591 (17.4) | 4563 (17.6) | 18 186 (17.7) |
| Hypertension (%) | 63 244 (48.7) | 12 621 (48.7) | 50 486 (49.1) |
| . | Training set (n = 129 788) . | Validation set (n = 25 893) . | Testing set (n = 102 926) . |
|---|---|---|---|
| Age, years (SD) | 62.99 (16.3) | 63.09 (16.3) | 62.97 (16.3) |
| Age groups (%) | |||
| <40 | 12 674 (9.8) | 2508 (9.7) | 10 094 (9.8) |
| 40–49 | 12 978 (10.0) | 2542 (9.8) | 10 234 (9.9) |
| 50–59 | 22 301 (17.2) | 4466 (17.2) | 17 909 (17.3) |
| 60–69 | 31 231 (24.1) | 6202 (24.0) | 24 970 (24.2) |
| 70–79 | 30 984 (23.9) | 6242 (24.1) | 24 077 (23.3) |
| 80+ | 19 620 (15.1) | 3929 (15.2) | 15 642 (15.2) |
| Female sex (%) | 61 514 (47.3) | 12 288 (47.4) | 48 988 (47.5) |
| Male sex (%) | 68 274 (53.7) | 13 605 (53.6) | 53 938 (53.5) |
| AS measurement severity level (%) | |||
| No AS | 114 646 (88.3) | 90 763 (88.1) | |
| Mild AS | 10 194 (7.9) | 1991 (7.7) | 8330 (8.1) |
| Moderate AS | 1605 (1.2) | 300 (1.5) | 1225 (1.2) |
| Severe AS | 3343 (2.6) | 642 (2.5) | 2608 (2.5) |
| Congestive heart failure (%) | 23 399 (18.0) | 4733 (18.3) | 18 531 (18.0) |
| Peripheral vascular disease (%) | 20 102 (15.5) | 4178 (16.1) | 16 134 (15.7) |
| Cerebrovascular disease (%) | 14 787 (11.4) | 3002 (11.6) | 11 879 (11.5) |
| Renal disease (%) | 15 641 (12.1) | 3168 (12.2) | 12 394 (12.0) |
| Chronic pulmonary disease (%) | 26 312 (20.3) | 5210 (20.1) | 20 932 (20.3) |
| Connective tissue disease-rheumatic disease (%) | 6273 (4.8) | 1226 (4.7) | 5103 (5.0) |
| Myocardial infarction (%) | 12 097 (9.3) | 2446 (9.4) | 9843 (9.6) |
| Diabetes (%) | 22 591 (17.4) | 4563 (17.6) | 18 186 (17.7) |
| Hypertension (%) | 63 244 (48.7) | 12 621 (48.7) | 50 486 (49.1) |
Any observed differences in comorbidities is a result of random chance.
| . | Training set (n = 129 788) . | Validation set (n = 25 893) . | Testing set (n = 102 926) . |
|---|---|---|---|
| Age, years (SD) | 62.99 (16.3) | 63.09 (16.3) | 62.97 (16.3) |
| Age groups (%) | |||
| <40 | 12 674 (9.8) | 2508 (9.7) | 10 094 (9.8) |
| 40–49 | 12 978 (10.0) | 2542 (9.8) | 10 234 (9.9) |
| 50–59 | 22 301 (17.2) | 4466 (17.2) | 17 909 (17.3) |
| 60–69 | 31 231 (24.1) | 6202 (24.0) | 24 970 (24.2) |
| 70–79 | 30 984 (23.9) | 6242 (24.1) | 24 077 (23.3) |
| 80+ | 19 620 (15.1) | 3929 (15.2) | 15 642 (15.2) |
| Female sex (%) | 61 514 (47.3) | 12 288 (47.4) | 48 988 (47.5) |
| Male sex (%) | 68 274 (53.7) | 13 605 (53.6) | 53 938 (53.5) |
| AS measurement severity level (%) | |||
| No AS | 114 646 (88.3) | 90 763 (88.1) | |
| Mild AS | 10 194 (7.9) | 1991 (7.7) | 8330 (8.1) |
| Moderate AS | 1605 (1.2) | 300 (1.5) | 1225 (1.2) |
| Severe AS | 3343 (2.6) | 642 (2.5) | 2608 (2.5) |
| Congestive heart failure (%) | 23 399 (18.0) | 4733 (18.3) | 18 531 (18.0) |
| Peripheral vascular disease (%) | 20 102 (15.5) | 4178 (16.1) | 16 134 (15.7) |
| Cerebrovascular disease (%) | 14 787 (11.4) | 3002 (11.6) | 11 879 (11.5) |
| Renal disease (%) | 15 641 (12.1) | 3168 (12.2) | 12 394 (12.0) |
| Chronic pulmonary disease (%) | 26 312 (20.3) | 5210 (20.1) | 20 932 (20.3) |
| Connective tissue disease-rheumatic disease (%) | 6273 (4.8) | 1226 (4.7) | 5103 (5.0) |
| Myocardial infarction (%) | 12 097 (9.3) | 2446 (9.4) | 9843 (9.6) |
| Diabetes (%) | 22 591 (17.4) | 4563 (17.6) | 18 186 (17.7) |
| Hypertension (%) | 63 244 (48.7) | 12 621 (48.7) | 50 486 (49.1) |
| . | Training set (n = 129 788) . | Validation set (n = 25 893) . | Testing set (n = 102 926) . |
|---|---|---|---|
| Age, years (SD) | 62.99 (16.3) | 63.09 (16.3) | 62.97 (16.3) |
| Age groups (%) | |||
| <40 | 12 674 (9.8) | 2508 (9.7) | 10 094 (9.8) |
| 40–49 | 12 978 (10.0) | 2542 (9.8) | 10 234 (9.9) |
| 50–59 | 22 301 (17.2) | 4466 (17.2) | 17 909 (17.3) |
| 60–69 | 31 231 (24.1) | 6202 (24.0) | 24 970 (24.2) |
| 70–79 | 30 984 (23.9) | 6242 (24.1) | 24 077 (23.3) |
| 80+ | 19 620 (15.1) | 3929 (15.2) | 15 642 (15.2) |
| Female sex (%) | 61 514 (47.3) | 12 288 (47.4) | 48 988 (47.5) |
| Male sex (%) | 68 274 (53.7) | 13 605 (53.6) | 53 938 (53.5) |
| AS measurement severity level (%) | |||
| No AS | 114 646 (88.3) | 90 763 (88.1) | |
| Mild AS | 10 194 (7.9) | 1991 (7.7) | 8330 (8.1) |
| Moderate AS | 1605 (1.2) | 300 (1.5) | 1225 (1.2) |
| Severe AS | 3343 (2.6) | 642 (2.5) | 2608 (2.5) |
| Congestive heart failure (%) | 23 399 (18.0) | 4733 (18.3) | 18 531 (18.0) |
| Peripheral vascular disease (%) | 20 102 (15.5) | 4178 (16.1) | 16 134 (15.7) |
| Cerebrovascular disease (%) | 14 787 (11.4) | 3002 (11.6) | 11 879 (11.5) |
| Renal disease (%) | 15 641 (12.1) | 3168 (12.2) | 12 394 (12.0) |
| Chronic pulmonary disease (%) | 26 312 (20.3) | 5210 (20.1) | 20 932 (20.3) |
| Connective tissue disease-rheumatic disease (%) | 6273 (4.8) | 1226 (4.7) | 5103 (5.0) |
| Myocardial infarction (%) | 12 097 (9.3) | 2446 (9.4) | 9843 (9.6) |
| Diabetes (%) | 22 591 (17.4) | 4563 (17.6) | 18 186 (17.7) |
| Hypertension (%) | 63 244 (48.7) | 12 621 (48.7) | 50 486 (49.1) |
Any observed differences in comorbidities is a result of random chance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
